Transfusion support in hematopoietic stem cell transplantation
- PMID: 36843378
- PMCID: PMC10133853
- DOI: 10.5045/br.2023.2023004
Transfusion support in hematopoietic stem cell transplantation
Abstract
Transfusion support for hematopoietic stem cell transplantation (HSCT) is an essential part of supportive care, and compatible blood should be transfused into recipients. As leukocyte antigen (HLA) matching is considered first and as the blood group does not impede HSCT, major, minor, bidirectional, and RhD incompatibilities occur that might hinder transfusion and cause adverse events. Leukocyte reduction in blood products is frequently used, and irradiation should be performed for blood products, except for plasma. To mitigate incompatibility and adverse events, local transfusion guidelines, hospital transfusion committees, and patient management should be considered.
Keywords: ABO blood group; Hematopoietic stem cell transplantation; RhD blood group; Transfusion.
Conflict of interest statement
No potential conflicts of interest relevant to this article were reported.
Figures
References
-
- Korean Society for Laboratory Medicine, author. Laboratory medicine. 6th ed. Seoul, Korea: Panmuneducation, 2021:1065–86.
-
- Fung M, Eder AF, Spitalnik SL, Westhoff CM. Technical manual. 19th ed. Bethesda, MD: AABB Press, 2017:683–91.
-
- Han K, Park K, Song E. Transfusion medicine. 4th ed. Seoul, Korea: Korea Medical Book Publishing Company, 2014:179–97.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
